中商官网
研究报告
中国生物制药（HK1177）
| 科目\年度 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 |
原始货币 |
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| 审计意见 |
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| 报表核心指标 |
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| 税后利润 |
531452.90 | 636468.20 | 509739.80 | 500261.80 | 1661479.00 | 434066.70 | 478784.50 | 1073285.00 | 365354.70 | 272850.70 | 291100.80 | 236105.40 | 178195.90 | 141747.20 |
| 营业收入 |
3183449.00 | 2886616.00 | 2798230.00 | 2878041.00 | 2686136.00 | 2364722.00 | 2423403.00 | 2088858.00 | 1481930.00 | 1354338.00 | 1455023.00 | 1237835.00 | 990119.60 | 749688.80 |
| 销售成本 |
570774.00 | 533621.80 | 498987.70 | 448761.60 | 533209.50 | 518232.00 | 492626.80 | 419693.20 | 309062.50 | 281662.00 | 324969.70 | 292053.10 | 222835.10 | 161058.70 |
| 税前利润 |
694339.60 | 527746.80 | 593357.90 | 577860.40 | 1857267.00 | 501304.40 | 569059.20 | 1142908.00 | 419583.90 | 320349.10 | 344388.40 | 280120.70 | 213651.00 | 172260.70 |
| 归属于母公司股东利润 |
234334.80 | 349983.40 | 233193.90 | 254357.00 | 1460841.00 | 277108.60 | 276154.20 | 904634.60 | 217095.10 | 163737.80 | 177869.20 | 151320.50 | 103676.40 | 89075.80 |
| 营业收入 |
3183449.00 | 2886616.00 | 2798230.00 | 2878041.00 | 2686136.00 | 2364722.00 | 2423403.00 | 2088858.00 | 1481930.00 | 1354338.00 | 1455023.00 | 1237835.00 | 990119.60 | 749688.80 |
| 其中：营业额 |
3183449.00 | 2886616.00 | 2798230.00 | 2878041.00 | 2686136.00 | 2364722.00 | 2423403.00 | 2088858.00 | 1481930.00 | 1354338.00 | 1455023.00 | 1237835.00 | 990119.60 | 749688.80 |
| 销售成本 |
570774.00 | 533621.80 | 498987.70 | 448761.60 | 533209.50 | 518232.00 | 492626.80 | 419693.20 | 309062.50 | 281662.00 | 324969.70 | 292053.10 | 222835.10 | 161058.70 |
| 毛利 |
2612675.00 | 2352994.00 | 2299242.00 | 2429280.00 | 2152926.00 | 1846490.00 | 1930776.00 | 1669165.00 | 1172868.00 | 1072676.00 | 1130053.00 | 945781.80 | 767284.40 | 588630.10 |
| 加：其他收入 |
52014.10 | 2251.10 | 99161.59 | 43089.30 | 105870.70 | 124122.30 | 86260.30 | 744316.10 | 64286.10 | 27453.10 | 39163.30 | 29318.20 | 18878.20 | 13925.30 |
| 减：销售费用 |
1099328.00 | 1007797.00 | 919335.10 | 980937.20 | 1051839.00 | 897263.50 | 931954.10 | 807854.40 | 591787.90 | 545313.70 | 589728.60 | 534252.70 | 441398.60 | 332254.40 |
| 管理费用 |
800977.20 | 717071.30 | 187328.40 | 189940.80 | 218523.40 | 265592.60 | 247741.80 | 218950.10 | 98694.50 | 103943.40 | 123404.60 | 82496.60 | 63831.20 | 66996.00 |
| 财务费用 |
-35527.80 | -20444.70 | 51106.50 | 43905.80 | 30861.70 | 32336.80 | 22995.00 | 15326.40 | 7794.50 | 7664.80 | 7981.20 | 4309.60 | 250.00 | 965.00 |
| 其他费用 |
90434.70 | 620165.60 | 470366.00 | 446332.20 | 463384.10 | 273792.10 | 256424.90 | 234433.30 | 160200.60 | 152607.50 | 136238.70 | 107599.70 | 90832.10 | 54097.20 |
| 经营溢利特殊科目 |
-- | -- | -147526.70 | -218094.90 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| 经营溢利 |
709477.20 | 539576.70 | 622740.90 | 593158.00 | 494188.30 | 501627.70 | 557920.70 | 1136917.00 | 378676.30 | 290599.60 | 311863.00 | 246441.50 | 189850.80 | 148242.80 |
| 加：应占联营公司业绩 |
-- | -- | -- | -- | -- | -- | 11138.50 | 5991.00 | 40907.60 | 29749.50 | 32525.40 | 33679.20 | 23800.20 | -- |
| 税前利润特殊科目 |
-15137.60 | -11829.90 | -29383.00 | -15297.60 | 1363079.00 | -323.30 | -- | -- | -- | -- | -- | -- | -- | 24017.90 |
| 税前利润 |
694339.60 | 527746.80 | 593357.90 | 577860.40 | 1857267.00 | 501304.40 | 569059.20 | 1142908.00 | 419583.90 | 320349.10 | 344388.40 | 280120.70 | 213651.00 | 172260.70 |
| 减：所得税费用 |
162886.70 | 49291.80 | 83618.09 | 77598.59 | 195788.00 | 67237.70 | 90274.70 | 69623.60 | 54229.20 | 47498.40 | 53287.60 | 44015.30 | 35455.10 | 30513.50 |
| 加：税后利润特殊科目 |
-- | 158013.20 | 48475.90 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| 税后利润 |
531452.90 | 636468.20 | 509739.80 | 500261.80 | 1661479.00 | 434066.70 | 478784.50 | 1073285.00 | 365354.70 | 272850.70 | 291100.80 | 236105.40 | 178195.90 | 141747.20 |
| 归属于母公司股东利润 |
234334.80 | 349983.40 | 233193.90 | 254357.00 | 1460841.00 | 277108.60 | 276154.20 | 904634.60 | 217095.10 | 163737.80 | 177869.20 | 151320.50 | 103676.40 | 89075.80 |
| 归属于非控制股股东利润 |
297118.10 | 286484.80 | 276545.90 | 245904.80 | 200638.10 | 156958.10 | 202630.30 | 168649.80 | 148259.60 | 109112.90 | 113231.60 | 84784.90 | 74519.50 | 52671.40 |
| 基本每股收益 |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 稀释每股收益 |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 其他综合收益 |
-174846.70 | 20509.00 | 8998.70 | -71353.80 | 20096.10 | 34134.90 | 8682.60 | 10406.00 | -19756.70 | 11038.00 | -43030.20 | -10577.90 | 17742.20 | 6824.90 |
| 综合收益总额 |
356606.20 | 656977.20 | 518738.50 | 428908.00 | 1681575.00 | 468201.60 | 487467.10 | 1083691.00 | 345598.00 | 283888.70 | 248070.60 | 225527.50 | 195938.10 | 148572.10 |
| 归属于母公司股东综合收益总额 |
59488.10 | 370774.70 | 242192.60 | 183003.20 | 1481189.00 | 311216.30 | 284767.80 | 911748.20 | 195537.20 | 173510.50 | 147050.40 | 144368.20 | 114693.00 | 94397.40 |
| 归属于非控制股股东综合收益总额 |
297118.10 | 286202.50 | 276545.90 | 245904.80 | 200386.10 | 156985.30 | 202699.30 | 171942.30 | 150060.80 | 110378.20 | 101020.20 | 81159.30 | 81245.10 | 54174.70 |